Schwartz P E, Smith J P
Am J Obstet Gynecol. 1980 Dec 15;138(8):1124-30. doi: 10.1016/s0002-9378(16)32778-8.
One hundred eighty-six patients with epithelial tumors of the ovary who were managed at the M. D. Anderson Hospital and Tumor Institute underwent an exploratory operation ("second-look" operation) to assess the status of the cancer. Fifty-eight patients were found to have no evidence of disease (NED) and chemotherapy was discontinued. Eight patients with advanced ovarian cancer had NED 5 or more years after negative second-look operations and were probably cured by chemotherapy. Seven patients who were found to have cancer at second-look operations had a change in management as a result of the operation and had NED 5 or more years later. The most important factors correlating with negative second-look operations were the stage of cancer, the amount of residual tumor left at the initial operation, and the number of courses of chemotherapy administered prior to the second-look operation. Survival after positive second-look operations varied directly with the volume of tumor found at the time of operation and the amount of tumor left behind at the second-look operation. Patients who were treated with radiation therapy had a poorer survival rate than those who were treated with chemotherapy after positive second-look operations.
186名在MD安德森癌症中心和肿瘤研究所接受治疗的卵巢上皮性肿瘤患者接受了探查手术(“二次探查”手术)以评估癌症状况。58名患者被发现无疾病证据(NED),化疗停止。8名晚期卵巢癌患者在二次探查手术阴性后5年或更长时间无疾病证据,可能通过化疗治愈。7名在二次探查手术中发现有癌症的患者因手术改变了治疗方案,5年或更长时间后无疾病证据。与二次探查手术阴性相关的最重要因素是癌症分期、初次手术时残留肿瘤的数量以及二次探查手术前给予的化疗疗程数。二次探查手术阳性后的生存率与手术时发现的肿瘤体积以及二次探查手术时残留的肿瘤数量直接相关。二次探查手术阳性后接受放疗的患者生存率低于接受化疗的患者。